Patents by Inventor John Louis Parker

John Louis Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210308449
    Abstract: Applying therapeutic neural stimuli involves monitoring for at least one of sensory input and movement of a user. In response to detection of sensory input or user movement, an increased stimulus dosage is delivered within a period of time corresponding to a duration of time for which the detected sensory input or user movement gives rise to masking, the increased stimulus dosage being configured to give rise to increased neural recruitment.
    Type: Application
    Filed: April 19, 2021
    Publication date: October 7, 2021
    Applicant: Saluda Medical Pty Ltd
    Inventor: John Louis Parker
  • Patent number: 11129980
    Abstract: An electrode assembly (1) for an active implantable medical device comprising: an elongated, biocompatible, electrically non-conductive body (3) having a first portion (7) and a second portion (9); one or more biocompatible, electrically conductive filaments (5) inside the elongated non-conductive body (3) between the first portion (7) and the second portion (9); and one or more fluid passages (11) along the elongated electrically non-conductive body (3) between the first portion (7) and second portion (9), wherein the one or more fluid passages (11) allow a surrounding fluid (13) of a patient to be in electrical contact with the one or more conductive filaments (5). There is also disclosed a method of manufacturing an electrode assembly.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: September 28, 2021
    Assignee: Saluda Medical Pty Limited
    Inventors: Peter Scott Vallack Single, Jonathan Brereton Scott, Steven Owen McCabe, John Louis Parker
  • Patent number: 11110270
    Abstract: Fitting a brain neurostimulator electrode array comprises positioning at least a first electrode in a desired target structure in a first cerebral hemisphere, and positioning at least a second electrode in a corresponding target structure in a contralateral cerebral hemisphere. Electrical stimuli are applied from the first electrode to the desired target structure. Neural responses observed at the second electrode in response to the electrical stimuli are recorded. The fitting of at least one of the first electrode and second electrode is assessed by reference to the recorded neural responses.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: September 7, 2021
    Assignee: Closed Loop Medical Pty Ltd
    Inventors: John Louis Parker, Gerrit Eduard Gmel
  • Publication number: 20210267518
    Abstract: A method is provided for processing a neural measurement obtained in the presence of noise, in order to detect whether a locally evoked neural response is present in the neural measurement. A first neural measurement is obtained from a first sense electrode. A second neural measurement is contemporaneously obtained from a second sense electrode spaced apart from the first electrode along a neural pathway of the neural response. A neural response decay is determined, being a measure of the decay in the neural response from the first sense electrode to the second sense electrode. A ratio of the neural response decay to an amplitude normalising term is calculated. From the ratio it is determined whether a locally evoked neural response is present in the neural measurement.
    Type: Application
    Filed: April 6, 2021
    Publication date: September 2, 2021
    Applicant: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Milan Obradovic
  • Publication number: 20210268293
    Abstract: An implantable neural stimulation device (101) having a body (103) containing stimulation electronics (105) and a battery (107). The device (101) has a first header (109) and a second header (117) that are respectively coupled to the body (103). In some examples the first header (109) contains a charge coil (111) and a connector (113) for stimulation leads (115) and the second header (117) contains a communication antenna (119). There is also disclosed a method of manufacturing an implantable neural stimulation device.
    Type: Application
    Filed: June 26, 2019
    Publication date: September 2, 2021
    Applicant: SALUDA MEDICAL PTY LIMITED
    Inventors: Peter Scott Vallack SINGLE, John Louis PARKER
  • Patent number: 11045129
    Abstract: An implantable device for estimating neural recruitment arising from a stimulus, has a plurality of electrodes. A stimulus source provides stimuli to be delivered from the electrodes to neural tissue. Measurement circuitry obtains a measurement of a neural signal sensed at the electrodes. A control unit is configured to control application of a selected stimulus to neural tissue using the stimulus electrodes; and after the selected neural stimulus, apply a probe stimulus having a short pulse width. A remnant neural response evoked by the probe stimulus is measured; and the control unit estimates from the remnant neural response a neural recruitment caused by the selected neural stimulus.
    Type: Grant
    Filed: March 21, 2018
    Date of Patent: June 29, 2021
    Assignee: Saluda Medical Pty Ltd.
    Inventors: John Louis Parker, James Hamilton Wah, Dean Michael Karantonis
  • Publication number: 20210162214
    Abstract: Estimating a nerve-to-electrode distance involves applying a stimulus from a stimulus electrode to a nerve. Neural measurements of at least one evoked compound action potential are obtained, and processed in order to estimate an originating state of stimulation exhibiting at least one characteristic defined by a single fibre size. A single fibre model is then applied to produce a measure of the nerve-to-electrode distance. Also provided for is estimation of a distribution of recruited fibres. Measurements of a compound action potential are obtained from sense electrodes spaced apart along a neural pathway. A conduction velocity of the compound action potential is determined from the latency between the measurements. From the conduction velocity a dominant recruited fibre diameter is determined. A rate of dispersion of the compound action potential between the sense electrodes is determined. From the rate of dispersion a distribution of diameters of the recruited fibre population is determined.
    Type: Application
    Filed: December 14, 2020
    Publication date: June 3, 2021
    Applicant: Saluda Medical Pty Ltd
    Inventor: John Louis Parker
  • Patent number: 11006857
    Abstract: A motor response of a muscle to neural stimulation is assessed. Electrical stimuli are applied from a first electrode to a selected neural pathway to evoke an efferent neural response. A slow neural response upon the neural pathway evoked by the electrical stimuli is observed. Based on the slow neural response, a motor response of at least one muscle to the stimuli is assessed.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: May 18, 2021
    Assignee: Closed Loop Medical Pty Ltd
    Inventor: John Louis Parker
  • Patent number: 11006846
    Abstract: A method is provided for processing a neural measurement obtained in the presence of noise, in order to detect whether a locally evoked neural response is present in the neural measurement. A first neural measurement is obtained from a first sense electrode. A second neural measurement is contemporaneously obtained from a second sense electrode spaced apart from the first electrode along a neural pathway of the neural response. A neural response decay is determined, being a measure of the decay in the neural response from the first sense electrode to the second sense electrode. A ratio of the neural response decay to an amplitude normalising term is calculated. From the ratio it is determined whether a locally evoked neural response is present in the neural measurement.
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: May 18, 2021
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Milan Obradovic
  • Publication number: 20210121696
    Abstract: Neurostimulation of a mixed nerve comprising a plurality of nerve fibre types. An implantable electrode array comprising a plurality of electrodes is positioned proximal to the mixed nerve. An electrical stimulus is delivered from at least one nominal stimulus electrode of the implantable electrode array, in accordance with a set of stimulus parameters. A recording of the electrophysiological response evoked by the electrical stimulus is obtained from at least one nominal recording electrode of the implantable electrode array. The recording is analysed by assessing one or more selected characteristics of the recording, and from the observed selected characteristics a level of recruitment of one or more fibre types recruited by the electrical stimulus is identified. The stimulus parameters are refined in a manner to effect selective recruitment of one or more fibre types relative to other fibre types of the mixed nerve.
    Type: Application
    Filed: April 29, 2019
    Publication date: April 29, 2021
    Applicant: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Gerrit Eduard Gmel
  • Patent number: 10918872
    Abstract: Communications along a neural pathway are provided. The neural pathway is stimulated at a first location, in order to evoke neural responses which propagate along the neural pathway, the neural responses being modulated with data. At a second location spaced apart from the first location along the neural pathway the evoked neural responses are sensed. The sensed neural responses are then demodulated to retrieve the data. The stimulation could comprise peripheral sensory stimulation, and the second location could be at an implanted electrode array.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: February 16, 2021
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Mark Staples
  • Publication number: 20210016091
    Abstract: A method of applying a neural stimulus with an implanted electrode array involves applying a sequence of stimuli configured to yield a therapeutic effect while suppressing psychophysical side effects. The stimuli sequence is configured such that a first stimulus recruits a portion of the fibre population, and a second stimulus is delivered within the refractory period following the first stimulus and the second stimulus being configured to recruit a further portion of the fibre population. Using an electrode array and suitable relative timing of the stimuli, ascending or descending volleys of evoked responses can be selectively synchronised or desynchronised to give directional control over responses evoked.
    Type: Application
    Filed: September 24, 2020
    Publication date: January 21, 2021
    Applicant: Saluda Medical Pty Limited
    Inventors: John Louis Parker, James Hamilton Wah
  • Patent number: 10894158
    Abstract: Estimating a nerve-to-electrode distance involves applying a stimulus from a stimulus electrode to a nerve. Neural measurements of at least one evoked compound action potential are obtained, and processed in order to estimate an originating state of stimulation exhibiting at least one characteristic defined by a single fibre size. A single fibre model is then applied to produce a measure of the nerve-to-electrode distance. Also provided for is estimation of a distribution of recruited fibres. Measurements of a compound action potential are obtained from sense electrodes spaced apart along a neural pathway. A conduction velocity of the compound action potential is determined from the latency between the measurements. From the conduction velocity a dominant recruited fibre diameter is determined. A rate of dispersion of the compound action potential between the sense electrodes is determined. From the rate of dispersion a distribution of diameters of the recruited fibre population is determined.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: January 19, 2021
    Assignee: Saluda Medical Pty Ltd
    Inventor: John Louis Parker
  • Patent number: 10849525
    Abstract: Monitoring brain neural activity comprises repeatedly applying electrical stimuli to evoke neural responses in the brain. Neural responses evoked by the stimuli are recorded. The recorded neural responses are assessed for changed characteristics over time, to monitor a time-varying effect on the recorded neural responses of local field potentials arising from a source other than the electrical stimuli.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: December 1, 2020
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Gerrit Eduard Gmel
  • Publication number: 20200282208
    Abstract: Applying therapeutic neural stimuli involves monitoring for at least one of sensory input and movement of a user. In response to detection of sensory input or user movement, an increased stimulus dosage is delivered within a period of time corresponding to a duration of time for which the detected sensory input or user movement gives rise to masking, the increased stimulus dosage being configured to give rise to increased neural recruitment.
    Type: Application
    Filed: March 18, 2020
    Publication date: September 10, 2020
    Applicant: Saluda Medical Pty Ltd
    Inventor: John Louis Parker
  • Publication number: 20200155240
    Abstract: A method of surgically positioning an electrode array at a desired implantation location relative to a nerve. A temporary probe electrode is temporarily positioned adjacent to the nerve and at a location which is caudorostrally separate to the desired implantation location of the electrode array. The implanted position of the probe electrode is temporarily fixed relative to the nerve. During implantation of the electrode array, electrical stimuli are applied from one of the temporarily fixed probe electrode and the electrode array, to evoke compound action potentials on the nerve. Compound action potentials evoked by the stimuli are sensed from at least one electrode of the other of the temporarily fixed probe electrode and the electrode array. From the sensed compound action potentials a position of the electrode array relative to the nerve is determined.
    Type: Application
    Filed: January 24, 2020
    Publication date: May 21, 2020
    Applicant: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Milan Obradovic
  • Publication number: 20200129108
    Abstract: A method for determining a desired location at which to apply a neural therapy. An array of electrodes is positioned proximal to neural tissue. A stimulus is applied from the array which evokes a neural compound action potential response in the neural tissue proximal to the array. A plurality of electrodes of the array simultaneously obtain respective measurements of the neural compound action potential response. From the measurements of the neural compound action potential response a desired location for a neural therapy is determined.
    Type: Application
    Filed: December 24, 2019
    Publication date: April 30, 2020
    Applicant: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Dean Michael Karantonis
  • Patent number: 10632307
    Abstract: Applying therapeutic neural stimuli involves monitoring for at least one of sensory input and movement of a user. In response to detection of sensory input or user movement, an increased stimulus dosage is delivered within a period of time corresponding to a duration of time for which the detected sensory input or user movement gives rise to masking, the increased stimulus dosage being configured to give rise to increased neural recruitment.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: April 28, 2020
    Assignee: Saluda Medical Pty Ltd
    Inventor: John Louis Parker
  • Patent number: 10588698
    Abstract: A method of surgically positioning an electrode array at a desired implantation location relative to a nerve. A temporary probe electrode is temporarily positioned adjacent to the nerve and at a location which is caudorostrally separate to the desired implantation location of the electrode array. The implanted position of the probe electrode is temporarily fixed relative to the nerve. During implantation of the electrode array, electrical stimuli are applied from one of the temporarily fixed probe electrode and the electrode array, to evoke compound action potentials on the nerve. Compound action potentials evoked by the stimuli are sensed from at least one electrode of the other of the temporarily fixed probe electrode and the electrode array. From the sensed compound action potentials a position of the electrode array relative to the nerve is determined.
    Type: Grant
    Filed: November 30, 2015
    Date of Patent: March 17, 2020
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Milan Obradovic
  • Patent number: 10568559
    Abstract: A method for determining a desired location at which to apply a neural therapy. An array of electrodes is positioned proximal to neural tissue. A stimulus is applied from the array which evokes a neural compound action potential response in the neural tissue proximal to the array. A plurality of electrodes of the array simultaneously obtain respective measurements of the neural compound action potential response. From the measurements of the neural compound action potential response a desired location for a neural therapy is determined.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: February 25, 2020
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Dean Michael Karantonis